Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain. - Wikidata - awgldk - TriplyDB

Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain.

Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain.

http://www.wikidata.org/entity/Q34030400

about

Opioids compared to placebo or other treatments for chronic low-back pain Management of moderate to severe chronic low back pain with buprenorphine buccal film using novel bioerodible mucoadhesive technology Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System.The Role of Resilience and Age on Quality of life in Patients with Pain Disorders The Pain and Sleep Questionnaire three-item index (PSQ-3): a reliable and valid measure of the impact of pain on sleep in chronic nonmalignant pain of various etiologies.Medical and psychological risks and consequences of long-term opioid therapy in women.Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.Buprenorphine 5, 10 and 20 μg/h transdermal patch: a guide to its use in chronic non-malignant pain.A review of pharmacotherapy for chronic low back pain with considerations for sports medicine.End-of-dose pain in chronic pain: does it vary with the use of different long-acting opioids?Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain.Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials.Transdermal Buprenorphine Patches for Postoperative Pain Control in Abdominal Surgery Safety of buprenorphine transdermal system in the management of pain in older adults.An Updated Overview of Low Back Pain Management in Primary Care.Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system.Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain.Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugs.Predicting medication persistence to buprenorphine transdermal system.Efficacy of transdermal buprenorphine patch on post-operative pain relief after elective spinal instrumentation surgery.Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers.Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials.

P2860

Q24200220-6986C4BF-F4E7-4005-8113-09437EF2D083 Q28080140-8C1C9DCD-F0EE-47B2-AE8F-1611EBE714DE Q31147169-5E7E7BA1-4488-4C73-B23C-01A1B7E27842 Q34367992-8DEB382D-60E5-4B22-B534-ACC58FD93E78 Q36138556-72D80052-31E6-478C-8AA0-C465F5C04980 Q36709787-F0D96231-515A-43E1-AF91-AC84B3194E94 Q36779246-709B7D0B-EF8D-47CB-94F7-135A10AC200F Q37964708-AFAB1A33-0C82-49C6-8880-4B3614FC08C8 Q37988549-4D888700-F72D-4E44-9181-E699868B7148 Q38073084-15901C15-771E-43F4-ABFE-ABD850F1785D Q38174282-D7648C0C-DDC8-4D55-ABAB-9AAF809D41E1 Q38400356-3E7D716B-07F2-4FA3-A89E-28C2527E9B76 Q38739959-AAD418F2-EDFA-4AB2-8C3B-27AAC5C9A32E Q39123423-B6416A47-9F8D-4647-B8DF-307ACE4E00D1 Q39168922-C62A1C75-3FBC-443D-8ECA-982E62ACADE3 Q40418728-C6812587-F101-48F5-B7A0-A522B8322D80 Q41539216-940CAAE0-E9D6-46C3-B612-B7E89AE88189 Q42237962-832A4EAB-AF94-40FB-80D1-057E7939C98A Q42685607-5C683C31-2002-46BE-80D4-70AEB75D1CBB Q44116782-9503E13A-D0D1-4C76-983B-91B43A1EE4B7 Q45163862-2F056DF5-79FC-4F5B-8580-23DBDCADAD6E Q47099470-DE963D79-ED63-4BBB-8B01-D5D3B738B407 Q47784541-8C1F9B85-8C3D-4201-B8A6-E899907885EB Q48000334-102DB34E-3134-43B7-BF3F-C91303835674

P2860

Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain.

http://www.wikidata.org/entity/Q34030400

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Buprenorphine transdermal syst ...... ts with chronic low back pain.

@ast

Buprenorphine transdermal syst ...... ts with chronic low back pain.

@en

Buprenorphine transdermal syst ...... ts with chronic low back pain.

@nl

type

label

Buprenorphine transdermal syst ...... ts with chronic low back pain.

@ast

Buprenorphine transdermal syst ...... ts with chronic low back pain.

@en

Buprenorphine transdermal syst ...... ts with chronic low back pain.

@nl

prefLabel

Buprenorphine transdermal syst ...... ts with chronic low back pain.

@ast

Buprenorphine transdermal syst ...... ts with chronic low back pain.

@en

Buprenorphine transdermal syst ...... ts with chronic low back pain.

@nl

P1433

Q34030400-7B355E26-E4DD-45FC-A1DC-576AC65F5073

P1476

Q34030400-B1B8FEBE-6E6A-401D-8BAF-9F14DAA8DB26

P2093

Q34030400-00FB20A0-729F-420A-A737-A75DB2450865

Q34030400-21FFAEE7-D472-481D-ABE8-D20C51F91A00

Q34030400-3940D975-F672-433D-8A34-CC6EB114F61A

Q34030400-4777C8F3-0920-44CE-B3B0-FBAF8D6167F2

Q34030400-52DD67D1-F5F5-49FB-BCC3-09AC9710CA60

Q34030400-7024AFCC-930D-4AB6-ABCA-4D7DE2D273E7

Q34030400-8C1F3D58-4B63-4805-A8EE-64054135B0AF

Q34030400-B3B89C40-DA85-4454-8977-C391FF4C6FD6

Q34030400-BB7719E5-3C2C-41CE-9060-C1B29712C76E

Q34030400-D3021081-3A94-490F-9E42-409FF85FE532

P2860

Q34030400-00103B45-A7E8-4A9E-8BC1-0BCEE0F37943

Q34030400-0150C80C-1189-4921-98FF-A6DD3C317BB2

Q34030400-2997F439-D4EA-424C-B2AD-93E37E89811D

Q34030400-34ED3BF7-B8AE-4A6A-9B1F-403CE23B8B50

Q34030400-3D838ABA-FE52-481E-B92F-AD9C2FDCC391

Q34030400-43C4FE1B-A02D-4AF8-BC23-C7D434646DA4

Q34030400-4BE05699-FA73-401D-98E8-5C0C40439C06

Q34030400-640B141F-CFE5-4CAB-B008-401A05DB1F4D

Q34030400-78D7BEDE-5B5C-42BB-AA48-8313B8EBA773

Q34030400-919D948A-5D74-4D87-B0EA-785B66AE5773

P304

Q34030400-757045B5-BEDC-48E8-B446-80FD0F1DEB45

P31

Q34030400-6F6A1BDE-77B2-42A3-9CF6-A78A7F96F615

P356

Q34030400-1B9B399A-417F-4E9C-9DED-EEE49796E39A

P433

Q34030400-A592E101-326A-4C70-93DC-33ADD1F0151D

P478

Q34030400-9E44AA28-09BD-4869-AC1F-ECBF180AD1C0

P577

Q34030400-AC0CA214-24FB-4622-9589-FEEC0D7A35C4

P698

Q34030400-8CB32AA8-AAC5-4F5D-BC12-41D0B44D5138

P921

Q34030400-49c85cc0-3034-4c2a-9519-40c45be15ca8

Q34030400-6641DDEE-27C2-4FB4-B243-05E0F57ED896

P932

Q34030400-5D374CF7-26BC-4D71-9CCB-5BEAFAAA3987

P356

P1433

Pain Research & Management

P1476

Buprenorphine transdermal syst ...... ts with chronic low back pain.

@en

P2093

Alexander J Clark

http://www.w3.org/2001/XMLSchema#string

Allan Gordon

http://www.w3.org/2001/XMLSchema#string

Andrew C Darke

http://www.w3.org/2001/XMLSchema#string

André D Beaulieu

http://www.w3.org/2001/XMLSchema#string

Dwight E Moulin

http://www.w3.org/2001/XMLSchema#string

John Eisenhoffer

http://www.w3.org/2001/XMLSchema#string

Patricia Quigley

http://www.w3.org/2001/XMLSchema#string

Paula S Piraino

http://www.w3.org/2001/XMLSchema#string

Saifudin Rashiq

http://www.w3.org/2001/XMLSchema#string

Zoltan Harsanyi

http://www.w3.org/2001/XMLSchema#string

P2860

Antidepressants for non-specific low back pain

The MOS 36-ltem Short-Form Health Survey (SF-36)

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group.

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.

Buprenorphine induces ceiling in respiratory depression but not in analgesia.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphon

Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.

Burden of major musculoskeletal conditions.

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

P304

169-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/216725

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20577660

http://www.w3.org/2001/XMLSchema#string

P921

P932

2912613

http://www.w3.org/2001/XMLSchema#string